by Chris Kamel | Oct 14, 2010
The reprogramming of differentiated adult cells into induced pluripotent stem (iPS) cells is accomplished by the expression of a small number of key genes. This is typically done by introducing DNA either by transfection or with viral vectors. Current methods,...
by Allison Van Winkle | Oct 8, 2010
High-throughput screening, in which many cell culture conditions can be tested using a combination of robotics, control software, and/or highly sensitive detection, allows researchers to explore new ideas quickly; thousands of combinations can be efficiently tested...
by Katie Moisse | Oct 6, 2010
Day two of the World Stem Cell Summit featured a much-anticipated update on a groundbreaking clinical trial launched in January to assess the safety and feasibility of injecting fetal stem cells into the spinal cords of people with Amyotrophic Lateral Sclerosis (ALS)....
by Stem Cell Network | Oct 4, 2010
What happens when two great scientists sit down for a one-on-one to talk about their work, their mentors and what motivates them? Yes, you get some great chemistry, but more than that, you get a fascinating look at the people and process behind the identification of...
by Stem Cell Network | Oct 1, 2010
For the second year running, mainstream media in Canada and abroad has picked up on Nobel buzz surrounding stem cell scientists James Till and Ernest McCulloch, both Senior Scientists at the Ontario Cancer Institute in Toronto. Speculation surrounding a Nobel prize...
by David Kent | Sep 30, 2010
Last week, a major kerfuffle erupted in the UK stem cell community as leading scientists and pro stem cell organizations argued that Britain’s range of economic austerity measures would jeopardize their ability to be a major player in translational research. Articles...
by Paul Krzyzanowski | Sep 28, 2010
In the RNA world hypothesis, RNA based biological life can exist without the need for DNA and proteins to store information, make decisions, and in general, control cells. In 1998, the discovery that small RNAs can play important roles in controlling cells...
by Allison Van Winkle | Sep 23, 2010
The transplantation of stem cells for use in regenerative medicine, where diseased or degenerated tissue is replaced with a new cell source, is an exciting field of research. However, prior to the implementation of a cell therapy, large amounts of cells will be...
by Michelle Ly | Sep 21, 2010
In my last post, I introduced the use of clinical stem cell therapy in treating multiple myelomas and lymphomas. The treatment focuses blood stem cells, known as hematopoietic progenitor cells (HPCs). By transplanting healthy HPCs into patients, nearly normal white...
by Katie Moisse | Sep 17, 2010
Replacing dead or dying cells with new, healthy ones is the holy grail of regenerative medicine. Even sustaining damaged cells with toxin-mopping, growth-factor-spewing stem-cell-derived support cells would be a tremendous feat. But while clinical trials have hinted...
Comments